Canada markets closed

Big Pharma Split Corp. (PRM.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
13.63+0.13 (+0.96%)
At close: 09:53AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 15.86M
Enterprise Value -9.41M
Trailing P/E 5.76
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)53.20
Price/Book (mrq)1.00
Enterprise Value/Revenue -30.64
Enterprise Value/EBITDA -2.45

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-9.13%
S&P500 52-Week Change 322.36%
52 Week High 315.35
52 Week Low 313.20
50-Day Moving Average 314.02
200-Day Moving Average 314.19

Share Statistics

Avg Vol (3 month) 31.2k
Avg Vol (10 day) 31.37k
Shares Outstanding 51.16M
Implied Shares Outstanding 61.16M
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Apr 15, 2024) 460
Short Ratio (Apr 15, 2024) 40.04
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.01%
Shares Short (prior month Mar 15, 2024) 4416

Dividends & Splits

Forward Annual Dividend Rate 41.24
Forward Annual Dividend Yield 49.08%
Trailing Annual Dividend Rate 31.24
Trailing Annual Dividend Yield 39.16%
5 Year Average Dividend Yield 49.09
Payout Ratio 478.30%
Dividend Date 3Apr 09, 2024
Ex-Dividend Date 4Apr 29, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -201.16%
Operating Margin (ttm)51.38%

Management Effectiveness

Return on Assets (ttm)-0.69%
Return on Equity (ttm)-3.63%

Income Statement

Revenue (ttm)320.82k
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-76.40%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-645.35k
Diluted EPS (ttm)-0.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)204.19k
Total Cash Per Share (mrq)0.17
Total Debt (mrq)10.3M
Total Debt/Equity (mrq)64.96%
Current Ratio (mrq)0.09
Book Value Per Share (mrq)13.62

Cash Flow Statement

Operating Cash Flow (ttm)11.86M
Levered Free Cash Flow (ttm)4.09M